<acronym id="xg0or"></acronym>
    1. <output id="xg0or"></output>
      <pre id="xg0or"><label id="xg0or"></label></pre>
    2. <td id="xg0or"><ruby id="xg0or"></ruby></td>

      1 / 3

      About Ribo

      Established in 2007, Suzhou Ribo Life Science Co. Ltd. is devoted to the advanced oligonucleotide therapeutics in China including siRNA, antisense and aptamer drugs based on proprietary intellectual properties. The core members of the R&D team include top experts in the fields of siRNA biotechnology, nucleic acid chemistry, drug delivery and development, consisting of both overseas returnees and domestic scientists. Ribo is committed to promoting siRNA and other RNA drugs, as well as technology innovation, in order to deliver more precise and efficient therapies to the patients worldwide.

      Technological Innovations

      Ribo continues to promote innovation of drugs development and the manufacturing process and has established an integrated drug R&D system covering drug design, target validation, drug delivery, quality study, pharmacological, toxicological, and pharmacokinetic evaluation, synthesis of monomers and oligonucleotides, and clinical study.

      siRNA delivery technology platform

      Oligonucleotide modification for enhanced stability platform

      Oligonucleotide therapeutic bioanalysis platform

      CMC Development of Oligonucleotide platform

      Oligonucleotide monomer platform

      Oligonucleotide sequence design and high-throughput screening platform

      Pipeline

      Driven by independent innovation and international cooperation, Ribo has built up robust R&D pipelines for oligonucleotide targeted at a number of therapeutic areas, such as ophthalmic diseases, metabolic diseases,central nervous system diseases, cancer, and liver diseases, in addition to anti-virus treatment.

      SR061

      NAION

      SR062

      Type 2 Diabetes

      SR063

      Prostate Cancer

      SR016

      Hepatitis B

      SR060

      Thrombotic Diseases

      SR043

      Hyperlipidemia

      亚洲va成无码人在线观看
      <acronym id="xg0or"></acronym>
      1. <output id="xg0or"></output>
        <pre id="xg0or"><label id="xg0or"></label></pre>
      2. <td id="xg0or"><ruby id="xg0or"></ruby></td>